Trade Prologis - PLD CFD

Market is not available at the momentMarket information is presented
as of 2026-10-05T19:46:05+00:00
Trading Conditions
Type
This financial market is available for CFD trading.
Learn more about:CFDs
CFD
Spread0.33
Long position overnight funding adjustment
Long position overnight funding adjustment

Margin. Your investment
$1,000.00
Overnight funding adjustment
Charges from full value of position
-0.022207 %
(-$4.44)

Trade size with leverage ~ $20,000.00

Money from leverage ~ $$19,000.00


-0.02221%
Short position overnight funding adjustment
Short position overnight funding adjustment

Margin. Your investment
$1,000.00
Overnight funding adjustment
Charges from full value of position
-0.000015 %
(-$0.00)

Trade size with leverage ~ $20,000.00

Money from leverage ~ $$19,000.00


-0.00002%
Overnight funding adjustment time21:00 (UTC)
CurrencyUSD
Min traded quantity0.1
Margin5.00%
Stock exchangeUnited States of America
Commission on trade10%
Guaranteed stop premium
A guaranteed stop-loss (GSL) fee is only charged if the GSL is triggered. Please consult the Charges and Fees section of our website for more details.
1%

1Our charge for executing your trade is the spread, the difference between the buy and sell price. Please consult the Charges and Fees section of our website for further information

Key Stats
Prev. Close128.78
Open128
1-Year Change9.36%
Day's Range127.66 - 129.01

Trade Prologis - PLD

About Prologis Inc

Prologis, Inc. is a real estate investment trust (REIT) company. The Company is involved in the logistics real estate business. It is engaged in the ownership, acquisition, development and management of logistics. It invests in real estate and other entities through which it co-invests with partners and investors. The Company's segments include Real Estate Operations and Strategic Capital. The Real Estate Operations segment consists of ownership and development of logistics properties. The Company's Strategic Capital segment includes management of unconsolidated co-investment ventures and other ventures.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Prologis Inc revenues increased 7% to $4.76B. Net income applicable to common stockholders increased 99% to $2.93B. Revenues reflect Real estate operations segment increase of 10% to $4.17B, Fixed Charge Coverage Ratio, Total increase of 15% to 11.4. Net income benefited from Reconciling items segment loss decrease of 75% to $281.5M, Real estate operations segment income increase of 10% to $3.1B.

Equity composition

Common Stock $.01 Par, 12/11, 500M auth., 459,401,000 issd. less shs in treas. 804,000. Insiders control 0.97%. IPO 11/97, 16,100,000 shs @ $21 byMorgan Stanley & Co. Inc. Sr. L Pref. Stk. $.01 Par, 2.3M auth., 2M issd. Sr. M $.01 Par, 2.3M auth., 2.3M issd. Sr.P Pref. Stk. $.01 Par, 2M auth., 2M issd. Sr. O Pref. Stk.$.01 Par, 3M auth., 3M issd.

Latest shares articles

BNP Paribas stock forecast
BNP Paribas stock forecast: Q2 earnings beat estimates
BNP Paribas is a French banking group whose recent developments include a Swift ledger transaction with HSBC for Siemens and continued focus on eurozone interest rates. Explore third-party BNP price targets and technical analysis. Past performance is not a reliable indicator of future results.
14 hours ago
Boeing stock forecast
Boeing stock forecast: FAA investigates Miami freighter crash
Boeing is a US aerospace manufacturer whose shares remain in focus after a 767-300 freighter crash in Miami prompted an FAA investigation. Explore third-party BA price targets and technical analysis. Past performance is not a reliable indicator of future results.
14 hours ago
CaixaBank stock forecast
CaixaBank stock forecast: BPI exits Angola market
CaixaBank is a Spanish bank whose Portuguese unit, Banco BPI, agreed to sell its 33.35% stake in Banco de Fomento de Angola for €388.5m. Explore third-party CABK price targets and technical analysis. Past performance is not a reliable indicator of future results.
15 hours ago
Valneva stock forecast
Valneva stock forecast: EMA validates Lyme vaccine application
Valneva is a French vaccine company listed on Euronext Paris. In August, the EMA validated the marketing-authorisation application for its Lyme disease vaccine candidate with Pfizer. Explore third-party VLA price targets. Past performance is not a reliable indicator of future results.
19 hours ago

User feedback and ratings

Showing our 4 & 5 star reviews. The specific details of the user have been intentionally anonymised to safeguard their privacy pursuant to GDPR requirements.

Ready to join a leading broker?

1. Create your account2. Make your first deposit3. Start when you’re ready